1. Home
  2. INBK vs CABA Comparison

INBK vs CABA Comparison

Compare INBK & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBK
  • CABA
  • Stock Information
  • Founded
  • INBK 1999
  • CABA 2017
  • Country
  • INBK United States
  • CABA United States
  • Employees
  • INBK N/A
  • CABA N/A
  • Industry
  • INBK Major Banks
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INBK Finance
  • CABA Health Care
  • Exchange
  • INBK Nasdaq
  • CABA Nasdaq
  • Market Cap
  • INBK 196.2M
  • CABA 157.4M
  • IPO Year
  • INBK N/A
  • CABA 2019
  • Fundamental
  • Price
  • INBK $27.81
  • CABA $1.60
  • Analyst Decision
  • INBK Buy
  • CABA Strong Buy
  • Analyst Count
  • INBK 4
  • CABA 7
  • Target Price
  • INBK $34.50
  • CABA $14.43
  • AVG Volume (30 Days)
  • INBK 41.3K
  • CABA 3.0M
  • Earning Date
  • INBK 07-23-2025
  • CABA 08-07-2025
  • Dividend Yield
  • INBK 0.87%
  • CABA N/A
  • EPS Growth
  • INBK 27.37
  • CABA N/A
  • EPS
  • INBK 2.40
  • CABA N/A
  • Revenue
  • INBK $114,609,000.00
  • CABA N/A
  • Revenue This Year
  • INBK $5.36
  • CABA N/A
  • Revenue Next Year
  • INBK $17.09
  • CABA N/A
  • P/E Ratio
  • INBK $11.55
  • CABA N/A
  • Revenue Growth
  • INBK 20.13
  • CABA N/A
  • 52 Week Low
  • INBK $19.54
  • CABA $0.99
  • 52 Week High
  • INBK $43.27
  • CABA $8.77
  • Technical
  • Relative Strength Index (RSI)
  • INBK 68.55
  • CABA 42.76
  • Support Level
  • INBK $26.63
  • CABA $1.65
  • Resistance Level
  • INBK $28.12
  • CABA $1.83
  • Average True Range (ATR)
  • INBK 0.91
  • CABA 0.15
  • MACD
  • INBK 0.40
  • CABA -0.06
  • Stochastic Oscillator
  • INBK 93.99
  • CABA 17.65

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: